BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 34596839)

  • 1. Short Review on Advances in Hydrogel-Based Drug Delivery Strategies for Cancer Immunotherapy.
    Seo HS; Wang CJ; Park W; Park CG
    Tissue Eng Regen Med; 2022 Apr; 19(2):263-280. PubMed ID: 34596839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
    Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
    J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
    Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery.
    Jin Q; Liu Z; Chen Q
    J Control Release; 2021 Jan; 329():882-893. PubMed ID: 33053396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injectable Hydrogel-Based Combination Cancer Immunotherapy for Overcoming Localized Therapeutic Efficacy.
    Kim J; Choi Y; Kim DH; Yoon HY; Kim K
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research progress on hydrogel-based drug therapy in melanoma immunotherapy.
    He W; Zhang Y; Qu Y; Liu M; Li G; Pan L; Xu X; Shi G; Hao Q; Liu F; Gao Y
    BMB Rep; 2024 Feb; 57(2):71-78. PubMed ID: 38053295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the application of hydrogels in immunotherapy of gastrointestinal tumors.
    Zheng H; Li M; Wu L; Liu W; Liu Y; Gao J; Lu Z
    Drug Deliv; 2023 Dec; 30(1):2161670. PubMed ID: 36587630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-based hydrogels with local drug release for cancer immunotherapy.
    Xie Z; Shen J; Sun H; Li J; Wang X
    Biomed Pharmacother; 2021 May; 137():111333. PubMed ID: 33571834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injectable hydrogels for personalized cancer immunotherapies.
    Mohaghegh N; Ahari A; Zehtabi F; Buttles C; Davani S; Hoang H; Tseng K; Zamanian B; Khosravi S; Daniali A; Kouchehbaghi NH; Thomas I; Serati Nouri H; Khorsandi D; Abbasgholizadeh R; Akbari M; Patil R; Kang H; Jucaud V; Khademhosseini A; Hassani Najafabadi A
    Acta Biomater; 2023 Dec; 172():67-91. PubMed ID: 37806376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing Hydrogels for On-Demand Therapy.
    Oliva N; Conde J; Wang K; Artzi N
    Acc Chem Res; 2017 Apr; 50(4):669-679. PubMed ID: 28301139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting Checkpoint Immunotherapy with Biomaterials.
    Liu L; Pan Y; Zhao C; Huang P; Chen X; Rao L
    ACS Nano; 2023 Feb; 17(4):3225-3258. PubMed ID: 36746639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer.
    Mikhail AS; Morhard R; Mauda-Havakuk M; Kassin M; Arrichiello A; Wood BJ
    Adv Drug Deliv Rev; 2023 Nov; 202():115083. PubMed ID: 37673217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy.
    Cui R; Wu Q; Wang J; Zheng X; Ou R; Xu Y; Qu S; Li D
    Front Bioeng Biotechnol; 2021; 9():723490. PubMed ID: 34368109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Biomaterial-Assisted Approaches for Immunotherapeutic Inhibition of Cancer Recurrence.
    Mozafari N; Jahanbekam S; Ashrafi H; Shahbazi MA; Azadi A
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1207-1234. PubMed ID: 38416058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
    Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
    Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally Injectable Hydrogels for Tumor Immunotherapy.
    Zhang X; Guo X; Wu Y; Gao J
    Gels; 2021 Nov; 7(4):. PubMed ID: 34842684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of injectable hydrogels in cancer immunotherapy.
    Liu C; Liao Y; Liu L; Xie L; Liu J; Zhang Y; Li Y
    Front Bioeng Biotechnol; 2023; 11():1121887. PubMed ID: 36815890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.